Bessemer Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,546
Closed -$204K 2040
2016
Q4
$204K Buy
2,546
+1,090
+75% +$86.5K ﹤0.01% 1079
2016
Q3
$116K Sell
1,456
-5,927
-80% -$478K ﹤0.01% 1077
2016
Q2
$576K Sell
7,383
-1,741,900
-100% -$124M ﹤0.01% 529
2016
Q1
$96.2M Buy
1,749,283
+415,641
+31% +$22.6M 0.54% 65
2015
Q4
$82.4M Buy
1,333,642
+1,332,084
+85,500% +$84M 0.46% 80
2015
Q3
$99K Buy
1,558
+181
+13% +$12.9K ﹤0.01% 841
2015
Q2
$101K Sell
1,377
-87
-6% -$6.29K ﹤0.01% 845
2015
Q1
$96K Sell
1,464
-1,056
-42% -$70.2K ﹤0.01% 833
2014
Q4
$164K Buy
2,520
+1,495
+146% +$96.3K ﹤0.01% 733
2014
Q3
$62K Buy
1,025
+611
+148% +$39.9K ﹤0.01% 840
2014
Q2
$29K Sell
414
-1,025
-71% -$66.4K ﹤0.01% 965
2014
Q1
$93K Sell
1,439
-10
-0.7% -$651 ﹤0.01% 748
2013
Q4
$90K Buy
1,449
+124
+9% +$7.18K ﹤0.01% 756
2013
Q3
$71K Sell
1,325
-101,270
-99% -$5.22M ﹤0.01% 773
2013
Q2
$4.68M Buy
+102,595
New +$4.45M 0.04% 212

Other funds holding STJ

Bessemer Group's STJ Position: Q1 2017 in Review

Bessemer Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,546 shares — an estimated $204K sold.

Bessemer Group first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $96.2M in Q1 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Bessemer Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Bessemer Group sold 2,546 St Jude Medical shares in Q1 2017, an estimated $204K.
  • Bessemer Group first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Bessemer Group's St Jude Medical position peaked at $96.2M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Bessemer Group's 13F filing for Q1 2017, filed 12 May 2017.